Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Über Lite Strategy

Gegründet

2018

Community

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Details zum Fundrasing

FinanzierungsrundeMengeBewertung
Date
Investoren
Post-IPO
$100.00M
--
2025-07-21
--